Summary

The global contrast media injectors market is expected to reach USD 2.3 billion by 2029 from USD 1.6 billion in 2024, at a CAGR of 8.0% from 2024 to 2029. Aging population, coupled with a rise in cancer and heart diseases, has increased the demand for these products. Cardiovascular diseases are more prevalent in old-age population. Contrast media helps to better visualize the blood vessels and improves diagnostic confidence. Moreover, increased benefits of contrast-mediated procedures have driven demand for contrast media injectors.

“The consumables segment of product segment held the largest share of the market in 2023”
The contrast media injectors market is segmented based on product into injector systems, consumables, and accessories. Contrast media consumables, like – syringes, tubing, vials and bottles, IV sets, etc., are the various products used to administer contrast agents for imaging procedures. The rising prevalence of chronic diseases and the growing demand for early diagnosis have led to an increase in diagnostic imaging procedures, boosting the demand for contrast media consumables.

“The dual-head injector segment of type segment held the largest share of the market in 2023”
The contrast media injectors market is segmented based on type into dual-head, single head, syringeless. The rising prevalence of heart diseases and growing opportunities in emerging countries drives this segment. There are number of companies providing contrast media injectors and consumables in China. Focus on innovation and strategies adopted by these players to expand their geographic presence offers lucrative opportunity for the growth of overall market. Dual-head injectors have notable benefits such as improved workflow efficiency and enhanced safety. The launch of new dual-head injectors in past few years has supported its adoption in end user facilities.

“The radiology segment for application segment to hold the largest market share in 2023”.
Based on application, the contrast media injectors market is segmented into interventional radiology, interventional cardiology, and radiology. Radiology was the major segment, accounting for the largest contrast media injectors market share in 2023. The rising incidence of chronic conditions is supported by the increasing aging population. This ultimately drives the adoption of contrast media injectors. A rising number of campaigns for the early detection of symptoms is also contributing to the increasing number of diagnostic imaging scans that ultimately support the adoption of contrast media injectors in end-user facilities.

“The diagnostic imaging centers segment for the end user segment is projected to register a significant CAGR during the forecast period.”
The contrast media injectors market is segmented by end-users into hospitals and diagnostic imaging centers. The hospitals accounted for a major end-user market share in 2023. The emphasis on minimally invasive treatment among the old-age population and increasing grants for the installation of advanced imaging equipment are driving the integration of contrast media injectors into hospital settings. Rising number of diagnostic imaging centers to fulfill the growing demand for imaging equipment and consistent rise in old-age population is expected to support the growth of this segment.

“The market in the Asia Pacific region is expected to witness the highest growth during the forecast period.”
Increased investment in healthcare infrastructure and services, especially in emerging economies, supports the expansion of diagnostic imaging and, consequently, the demand for contrast injectors. Key players in the market are focusing on expanding their presence in Asia Pacific market to cater the increasing demand for diagnostic scans. Moreover, the proliferation of diagnostic centers, particularly in APAC region, increases the availability and accessibility of imaging services, further driving the demand for contrast media injectors.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–30%, Tier 2–42%, and Tier 3– 28%
• By Designation: Director-level–10%, C-level–14%, and Others–76%
• By Region: North America–40%, Europe–30%, Asia Pacific–22%, Latin America–6%, and the Middle East & Africa–2%

The prominent players in the contrast media injectors market are Bayer AG (Germany), Bracco Imaging S.p.A. (Italy), Guerbet (France), Medtron AG (Germany), Ulrich GmbH & Co. Kg (Germany), and Nemoto Kyorindo (Japan), Sino MDT (China)among others.

Research Coverage

This report studies the contrast media injectors market based on product, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report
The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall contrast media injectors market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:
• Analysis of key drivers (increasing prevalence of cancer and cardiovascular diseases, growing adoption of contrast-mediated CT and MRI procedures, growing approvals of contrast media), restraints (high cost of contrast media injectors systems), opportunities (rising healthcare expenditure across emerging countries), and challenges (dearth of trained professionals) influencing the growth of the contrast media injectors market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the contrast media injectors market
• Market Development: Comprehensive information about lucrative markets–the report analyses the contrast media injectors market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the contrast media injectors market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as Bayer AG (Germany), Guerbet (France), Bracco Imaging S.p.A. (Italy), Ulrich GmbH & Co. Kg (Germany), Medtron AG (Germany), and Nemoto Kyorindo (Japan).

ページTOPに戻る

Table of Contents

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS & EXCLUSIONS 30
1.3 MARKET SCOPE 30
1.3.1 MARKETS COVERED 30
1.3.2 YEARS CONSIDERED 31
1.3.3 CURRENCY CONSIDERED 31
1.4 STAKEHOLDERS 31
1.5 SUMMARY OF CHANGES 32
1.6 RECESSION IMPACT 32
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
FIGURE 1 RESEARCH DESIGN 33
2.1.1 SECONDARY RESEARCH 34
2.1.2 PRIMARY RESEARCH 34
2.1.2.1 Primary sources 35
2.1.2.2 Key industry insights 36
2.1.2.3 Breakdown of primaries 36
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 36
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 37
2.2 MARKET SIZE ESTIMATION 37
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 38
2.2.1 BOTTOM-UP APPROACH 38
2.2.1.1 Approach 1: Company revenue estimation approach 38
FIGURE 5 CONTRAST MEDIA INJECTORS MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION) 39
2.2.1.2 Approach 2: Customer-based market estimation 39
FIGURE 6 CONTRAST MEDIA INJECTORS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 40
2.2.1.3 Growth forecast 40
2.2.1.4 CAGR projections 40
FIGURE 7 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS 40
2.3 DATA TRIANGULATION METHODOLOGY 41
FIGURE 8 DATA TRIANGULATION METHODOLOGY 41
2.4 RESEARCH LIMITATIONS 41
2.5 MARKET SHARE ASSESSMENT 42
2.5.1 STUDY ASSUMPTIONS 42
2.5.2 GROWTH RATE ASSUMPTIONS 43
2.6 RISK ASSESSMENT 43
TABLE 1 RISK ASSESSMENT ANALYSIS 43
2.7 RECESSION IMPACT ANALYSIS 43
3 EXECUTIVE SUMMARY 44
FIGURE 9 CONTRAST MEDIA INJECTORS MARKET, PRODUCT, 2024 VS. 2029 (USD MILLION) 44
FIGURE 10 CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 45
FIGURE 11 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 45
FIGURE 12 CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 46
FIGURE 13 GEOGRAPHIC SNAPSHOT OF CONTRAST MEDIA INJECTORS MARKET 46
4 PREMIUM INSIGHTS 48
4.1 CONTRAST MEDIA INJECTORS MARKET OVERVIEW 48
FIGURE 14 GROWING ADOPTION OF CONTRAST-MEDIATED CT AND MRI DIAGNOSTIC PROCEDURES TO DRIVE MARKET 48
4.2 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT AND COUNTRY (2023) 49
FIGURE 15 CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US (2023) 49
4.3 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 49
FIGURE 16 INTERVENTIONAL CARDIOLOGY SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 49
4.4 CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 50
FIGURE 17 DIAGNOSTIC IMAGING CENTERS SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 50
4.5 CONTRAST MEDIA INJECTORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 50
FIGURE 18 EMERGING MARKETS PROJECTED TO REACH HIGHER GROWTH RATES DURING FORECAST PERIOD 50
5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
5.2 MARKET DYNAMICS 51
FIGURE 19 CONTRAST MEDIA INJECTORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51
5.2.1 DRIVERS 52
5.2.1.1 Rising incidence of cancer and cardiovascular diseases 52
FIGURE 20 NEWLY DIAGNOSED CANCER CASES (MILLION) 52
TABLE 2 PROJECTED INCREASE IN GLOBAL NUMBER OF CANCER PATIENTS, 2020 VS. 2030 VS. 2040 53
5.2.1.2 Increasing volume of contrast-mediated MRI and CT procedures 53
TABLE 3 NUMBER OF MRI EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2019−2021 54
TABLE 4 NUMBER OF CT EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2019−2021 54
5.2.1.3 Growing approvals for CT and MRI contrast media to fuel demand for injectors 54
5.2.1.4 Favorable reimbursements in developed markets 55
5.2.2 RESTRAINTS 56
5.2.2.1 High cost of contrast media injectors 56
5.2.3 OPPORTUNITIES 57
5.2.3.1 High growth potential of emerging economies 57
5.2.3.2 Growing focus on mammography and nuclear imaging injectors 57
5.2.3.3 IT-enabled injector solutions 57
5.2.4 CHALLENGES 58
5.2.4.1 Shortage of skilled professionals and limited technical expertise 58
5.3 VALUE CHAIN ANALYSIS 59
5.3.1 RESEARCH & DEVELOPMENT 59
5.3.2 MANUFACTURING & ASSEMBLY 59
5.3.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 59
FIGURE 21 CONTRAST MEDIA INJECTORS MARKET: VALUE CHAIN ANALYSIS 60
5.4 SUPPLY CHAIN ANALYSIS 61
5.4.1 PROMINENT COMPANIES 61
5.4.2 SMALL AND MEDIUM-SIZED ENTERPRISES 61
5.4.3 END USERS 61
FIGURE 22 CONTRAST MEDIA INJECTORS MARKET: SUPPLY CHAIN ANALYSIS 61
5.5 ECOSYSTEM ANALYSIS 62
FIGURE 23 PARENT MARKET: ECOSYSTEM ANALYSIS 62
TABLE 5 CONTRAST MEDIA INJECTORS MARKET: ROLE IN ECOSYSTEM 62
5.6 REGULATORY ANALYSIS 63
TABLE 6 REGULATORY APPROVALS REQUIRED FOR CONTRAST MEDIA INJECTORS, BY COUNTRY 63
5.6.1 REGULATORY BODIES AND GOVERNMENT AGENCIES 64
5.6.1.1 North America: Regulatory bodies and government agencies 64
TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES 64
5.6.1.2 Europe: Regulatory bodies and government agencies 64
TABLE 8 EUROPE: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES 64
5.6.1.3 Asia Pacific: Regulatory bodies and government agencies 65
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES 65
5.6.1.4 Latin America: Regulatory bodies and government agencies 65
TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES 65
5.6.1.5 Middle East & Africa: Regulatory bodies and government agencies 66
TABLE 11 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES 66
5.6.2 REGULATORY GUIDELINES 66
5.6.2.1 US 66
TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION 66
TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 67
FIGURE 24 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES 67
5.6.2.2 Canada 67
TABLE 14 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 67
FIGURE 25 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 68
5.6.2.3 Europe 69
FIGURE 26 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES 70
5.6.2.4 Asia Pacific 70
5.6.2.4.1 Japan 70
TABLE 15 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA) 71
5.6.2.4.2 China 71
TABLE 16 CHINA: CLASSIFICATION OF MEDICAL DEVICES 71
5.6.2.4.3 India 72
5.6.2.4.4 Brazil 73
5.7 REIMBURSEMENT SCENARIO 73
TABLE 17 MEDICAL REIMBURSEMENT CODES FOR CONTRAST MEDIA IN US, 2023 73
5.8 INVESTMENT & FUNDING SCENARIO 76
FIGURE 27 NUMBER OF DEALS & FUNDING INITIATIVES IN CONTRAST MEDIA INJECTORS MARKET, 2018−2022 (USD MILLION) 76
FIGURE 28 NUMBER OF INVESTOR DEALS IN CONTRAST MEDIA INJECTORS MARKET, BY KEY PLAYER, 2018–2022 77
FIGURE 29 VALUE OF INVESTOR DEALS IN CONTRAST MEDIA INJECTORS MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION) 77
5.9 PRICING ANALYSIS 77
FIGURE 30 AVERAGE SELLING PRICE TREND OF CONTRAST MEDIA INJECTORS, BY PRODUCT 78
FIGURE 31 AVERAGE SELLING PRICE TREND OF CONTRAST MEDIA INJECTORS, BY REGION 78
TABLE 18 AVERAGE SELLING PRICE OF CONTRAST MEDIA INJECTORS, BY REGION 79
5.10 TRADE ANALYSIS 80
TABLE 19 IMPORT DATA FOR CONTRAST MEDIA INJECTORS (HS CODE 9018), BY COUNTRY, 2019–2023 (USD THOUSAND) 80
TABLE 20 EXPORT DATA FOR CONTRAST MEDIA INJECTORS (HS CODE 9018), BY COUNTRY, 2018–2022 (USD THOUSAND) 80
5.11 PATENT ANALYSIS 81
FIGURE 32 PATENT ANALYSIS: CONTRAST MEDIA INJECTORS MARKET (2013–2023) 81
5.12 PORTER’S FIVE FORCE ANALYSIS 82
TABLE 21 PORTER’S FIVE FORCES ANALYSIS: CONTRAST MEDIA INJECTORS MARKET 82
5.12.1 THREAT OF NEW ENTRANTS 82
5.12.2 THREAT OF SUBSTITUTES 82
5.12.3 BARGAINING POWER OF SUPPLIERS 82
5.12.4 BARGAINING POWER OF BUYERS 83
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 83
5.13 KEY CONFERENCES & EVENTS IN 2024–2025 83
TABLE 22 LIST OF MAJOR CONFERENCES & EVENTS IN CONTRAST MEDIA INJECTORS MARKET, 2024–2025 83
5.14 CASE STUDY ANALYSIS 85
TABLE 23 CASE STUDY 1: CARDIAC ENHANCEMENT ANALYSIS VIA CONTRAST MEDIA INJECTORS 85
5.15 TECHNOLOGY ANALYSIS 85
5.15.1 KEY TECHNOLOGIES 85
5.15.1.1 MRI contrast media injectors 85
5.15.1.2 CT contrast media injectors 86
5.15.1.3 Angiography contrast media injectors 87
5.15.2 COMPLEMENTARY TECHNOLOGIES 88
5.15.2.1 Diagnostic imaging modalities 88
5.15.3 ADJACENT TECHNOLOGIES 88
5.15.3.1 Artificial intelligence with automated data systems 88
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 88
FIGURE 33 REVENUE SHIFT IN CONTRAST MEDIA INJECTORS MARKET 89
5.17 KEY STAKEHOLDERS & BUYING CRITERIA 89
5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS 89
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PRIMARY FACTORS 89
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 90
FIGURE 35 BUYING CRITERIA FOR END USERS 90
TABLE 25 INFLUENCE OF END USERS ON BUYING PROCESS 90
FIGURE 36 INFLUENCE OF STAKEHOLDERS. BY END USER 91
TABLE 26 INFLUENCE OF STAKEHOLDERS, BY END USER 91
5.17.2 BUYING CRITERIA 91
FIGURE 37 KEY BUYING CRITERIA FOR PROCESS CONTRAST MEDIA INJECTORS 91
TABLE 27 KEY BUYING CRITERIA FOR CONTRAST MEDIA INJECTORS 92
5.18 UNMET NEEDS & KEY PAIN POINTS 92
TABLE 28 CONTRAST MEDIA INJECTORS MARKET: CURRENT UNMET NEEDS 92
5.19 ARTIFICIAL INTELLIGENCE (AI) IN CONTRAST MEDIA INJECTORS MARKET 93
6 CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT 94
6.1 INTRODUCTION 95
TABLE 29 CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 95
6.2 INJECTOR SYSTEMS 95
TABLE 30 CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 95
TABLE 31 CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 96
6.2.1 CT INJECTORS 96
6.2.1.1 Increasing number of CT scans to boost demand 96
TABLE 32 CT INJECTORS MARKET, BY REGION, 2022–2029 (USD MILLION) 96
6.2.2 MRI INJECTORS 97
6.2.2.1 Rising funding initiatives for development of advanced systems to propel market 97
TABLE 33 MRI INJECTORS MARKET, BY REGION, 2022–2029 (USD MILLION) 97
6.2.3 ANGIOGRAPHY INJECTORS 98
6.2.3.1 High uptake of cardiac catheterization procedures to drive market 98
TABLE 34 ANGIOGRAPHY INJECTORS MARKET, BY REGION, 2022–2029 (USD MILLION) 98
6.2.4 OTHER INJECTORS 98
6.3 CONSUMABLES 99
TABLE 35 CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 99
TABLE 36 CONTRAST MEDIA CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 99
6.3.1 SYRINGES 99
6.3.1.1 Diverse size range to fuel uptake 99
TABLE 37 SYRINGES MARKET, BY REGION, 2022–2029 (USD MILLION) 100
6.3.2 TUBES 100
6.3.2.1 Increasing demand for single-use products to drive market 100
TABLE 38 TUBES MARKET, BY REGION, 2022–2029 (USD MILLION) 100
6.3.3 OTHER CONSUMABLES 100
TABLE 39 OTHER CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 101
6.4 ACCESSORIES 101
6.4.1 ABILITY TO ENHANCE WORKFLOW EFFICIENCY TO SUPPORT MARKET GROWTH 101
TABLE 40 CONTRAST MEDIA ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION) 101
7 CONTRAST MEDIA INJECTORS MARKET, BY TYPE 102
7.1 INTRODUCTION 103
TABLE 41 CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 103
7.2 SINGLE-HEAD INJECTORS 103
7.2.1 COST-EFFICIENT AND USER-FRIENDLY DESIGN TO PROPEL MARKET 103
TABLE 42 CONTRAST MEDIA INJECTORS MARKET FOR SINGLE-HEAD INJECTORS, BY REGION, 2022–2029 (USD MILLION) 103
7.3 DUAL-HEAD INJECTORS 104
7.3.1 PRECISE CONTROL AND ENHANCED PATIENT SAFETY TO BOOST DEMAND 104
TABLE 43 CONTRAST MEDIA INJECTORS MARKET FOR DUAL-HEAD INJECTORS, BY REGION, 2022–2029 (USD MILLION) 104
7.4 SYRINGELESS INJECTORS 104
7.4.1 DIRECT ADMINISTRATION VIA TUBING TO SUPPORT MARKET GROWTH 104
TABLE 44 CONTRAST MEDIA INJECTORS MARKET FOR SYRINGELESS INJECTORS, BY REGION, 2022–2029 (USD MILLION) 105
8 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION 106
8.1 INTRODUCTION 107
TABLE 45 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 107
8.2 RADIOLOGY 107
8.2.1 RISING NUMBER OF RADIOLOGY PROCEDURES TO DRIVE MARKET 107
TABLE 46 CONTRAST MEDIA INJECTORS MARKET FOR RADIOLOGY, BY REGION, 2022–2029 (USD MILLION) 107
8.3 INTERVENTIONAL CARDIOLOGY 108
8.3.1 RISING UPTAKE OF CORONARY CT ANGIOGRAMS TO PROPEL MARKET 108
TABLE 47 CONTRAST MEDIA INJECTORS MARKET FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2022–2029 (USD MILLION) 108
8.4 INTERVENTIONAL RADIOLOGY 109
8.4.1 INCREASING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO SUPPORT MARKET GROWTH 109
TABLE 48 CONTRAST MEDIA INJECTORS MARKET FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2022–2029 (USD MILLION) 109
9 CONTRAST MEDIA INJECTORS MARKET, BY END USER 110
9.1 INTRODUCTION 111
TABLE 49 CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022–2029 (USD MILLION) 111
9.2 HOSPITALS 111
9.2.1 HIGH PURCHASING POWER FOR ADVANCED EQUIPMENT TO SUPPORT MARKET GROWTH 111
TABLE 50 CONTRAST MEDIA INJECTORS MARKET FOR HOSPITALS, BY REGION, 2022–2029 (USD MILLION) 112
9.3 DIAGNOSTIC IMAGING CENTERS 112
9.3.1 INCREASING ESTABLISHMENT OF PRIVATE IMAGING CENTERS TO PROPEL MARKET 112
TABLE 51 CONTRAST MEDIA INJECTORS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2022–2029 (USD MILLION) 112
10 CONTRAST MEDIA INJECTORS MARKET, BY REGION 113
10.1 INTRODUCTION 114
TABLE 52 CONTRAST MEDIA INJECTORS MARKET, BY REGION, 2022–2029 (USD MILLION) 114
10.2 NORTH AMERICA 114
FIGURE 38 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET SNAPSHOT 115
TABLE 53 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 115
TABLE 54 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 116
TABLE 55 NORTH AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 116
TABLE 56 NORTH AMERICA: CONTRAST MEDIA INJECTORS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 116
TABLE 57 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 117
TABLE 58 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 117
TABLE 59 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022–2029 (USD MILLION) 117
10.2.1 NORTH AMERICA: RECESSION IMPACT 117
10.2.2 US 118
10.2.2.1 Rising adoption of technologically advanced products to drive market 118
TABLE 60 US: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 118
TABLE 61 US: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 119
TABLE 62 US: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 119
10.2.3 CANADA 119
10.2.3.1 Rising investments in medical imaging equipment to drive market 119
TABLE 63 CANADA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 120
TABLE 64 CANADA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 120
TABLE 65 CANADA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 121
10.3 EUROPE 121
TABLE 66 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 121
TABLE 67 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 122
TABLE 68 EUROPE: CONTRAST MEDIA INJECTORS SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 122
TABLE 69 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 122
TABLE 70 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 123
TABLE 71 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022–2029 (USD MILLION) 123
10.3.1 EUROPE: RECESSION IMPACT 123
10.3.2 GERMANY 123
10.3.2.1 Advancements in imaging technologies to fuel uptake 123
TABLE 72 GERMANY: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 124
TABLE 73 GERMANY: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 124
TABLE 74 GERMANY: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 125
10.3.3 FRANCE 125
10.3.3.1 Increasing prevalence of cancer to propel market 125
TABLE 75 FRANCE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 125
TABLE 76 FRANCE: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 126
TABLE 77 FRANCE: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 126
10.3.4 UK 126
10.3.4.1 High incidence of CVD to propel market 126
TABLE 78 UK: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 127
TABLE 79 UK: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 127
TABLE 80 UK: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 128
10.3.5 ITALY 128
10.3.5.1 Rising incidence of chronic diseases to support market growth 128
TABLE 81 ITALY: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 128
TABLE 82 ITALY: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 129
TABLE 83 ITALY: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 129
10.3.6 SPAIN 129
10.3.6.1 Shortage of skilled radiologists to restrain market 129
TABLE 84 SPAIN: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 130
TABLE 85 SPAIN: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 130
TABLE 86 SPAIN: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 130
10.3.7 REST OF EUROPE 131
TABLE 87 REST OF EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 131
TABLE 88 REST OF EUROPE: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 132
TABLE 89 REST OF EUROPE: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 132
10.4 ASIA PACIFIC 132
FIGURE 39 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET SNAPSHOT 133
TABLE 90 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 91 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 134
TABLE 92 ASIA PACIFIC: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 134
TABLE 93 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 135
TABLE 94 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 135
TABLE 95 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022–2029 (USD MILLION) 135
10.4.1 ASIA PACIFIC: RECESSION IMPACT 135
10.4.2 JAPAN 136
10.4.2.1 Rising geriatric population and subsequent increase in chronic diseases to drive market 136
TABLE 96 JAPAN: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 136
TABLE 97 JAPAN: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 137
TABLE 98 JAPAN: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 137
10.4.3 CHINA 137
10.4.3.1 Rising incidence of cancer and increasing establishment of hospitals to boost demand 137
TABLE 99 CHINA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 138
TABLE 100 CHINA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 138
TABLE 101 CHINA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 138
10.4.4 INDIA 139
10.4.4.1 Growing investments in radiology to propel market 139
TABLE 102 INDIA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 139
TABLE 103 INDIA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 140
TABLE 104 INDIA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 140
10.4.5 AUSTRALIA 140
10.4.5.1 Increasing R&D investments for advanced diagnostic modalities to drive market 140
TABLE 105 AUSTRALIA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 141
TABLE 106 AUSTRALIA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 141
TABLE 107 AUSTRALIA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 142
10.4.6 SOUTH KOREA 142
10.4.6.1 Favorable reimbursements for diagnostic procedures to support market growth 142
TABLE 108 SOUTH KOREA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 142
TABLE 109 SOUTH KOREA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 143
TABLE 110 SOUTH KOREA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 143
10.4.7 REST OF ASIA PACIFIC 143
TABLE 111 REST OF ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 144
TABLE 112 REST OF ASIA PACIFIC: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 144
TABLE 113 REST OF ASIA PACIFIC: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 145
10.5 LATIN AMERICA 145
TABLE 114 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 115 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 146
TABLE 116 LATIN AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 146
TABLE 117 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 146
TABLE 118 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 147
TABLE 119 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022–2029 (USD MILLION) 147
10.5.1 LATIN AMERICA: RECESSION IMPACT 147
10.5.2 BRAZIL 148
10.5.2.1 Growing awareness of early disease detection & diagnosis to drive market 148
TABLE 120 BRAZIL: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 148
TABLE 121 BRAZIL: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 148
TABLE 122 BRAZIL: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 149
10.5.3 MEXICO 149
10.5.3.1 Inadequate healthcare infrastructure to restrain market 149
TABLE 123 MEXICO: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 149
TABLE 124 MEXICO: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 150
TABLE 125 MEXICO: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 150
10.5.4 REST OF LATIN AMERICA 150
TABLE 126 REST OF LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 151
TABLE 127 REST OF LATIN AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 151
TABLE 128 REST OF LATIN AMERICA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 151
10.6 MIDDLE EAST & AFRICA 152
10.6.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET 152
TABLE 129 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 152
TABLE 130 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 153
TABLE 131 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022–2029 (USD MILLION) 153
TABLE 132 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 153
TABLE 133 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022–2029 (USD MILLION) 154
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 154
11 COMPETITIVE LANDSCAPE 155
11.1 OVERVIEW 155
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 155
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CONTRAST MEDIA INJECTORS MARKET 155
TABLE 134 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES 155
11.3 REVENUE ANALYSIS 156
FIGURE 40 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN CONTRAST MEDIA INJECTORS MARKET (2019−2023) 157
11.4 MARKET SHARE ANALYSIS 157
FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023) 157
TABLE 135 CONTRAST MEDIA INJECTORS MARKET: DEGREE OF COMPETITION 158
11.4.1 RANKING OF KEY MARKET PLAYERS 159
FIGURE 42 RANKING OF KEY PLAYERS IN CONTRAST MEDIA INJECTORS MARKET, 2023 159
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 159
11.5.1 STARS 159
11.5.2 EMERGING LEADERS 159
11.5.3 PERVASIVE PLAYERS 159
11.5.4 PARTICIPANTS 160
FIGURE 43 CONTRAST MEDIA INJECTORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 160
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 161
11.5.5.1 Company footprint 161
FIGURE 44 CONTRAST MEDIA INJECTORS MARKET: COMPANY FOOTPRINT 161
11.5.5.2 Product footprint 161
TABLE 136 CONTRAST MEDIA INJECTORS MARKET: PRODUCT FOOTPRINT 161
11.5.5.3 Application footprint 162
TABLE 137 CONTRAST MEDIA INJECTORS MARKET: APPLICATION FOOTPRINT 162
11.5.5.4 End-user footprint 163
TABLE 138 CONTRAST MEDIA INJECTORS MARKET: END-USER FOOTPRINT 163
11.5.5.5 Region footprint 164
TABLE 139 CONTRAST MEDIA INJECTORS MARKET: REGION FOOTPRINT 164
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 164
11.6.1 PROGRESSIVE COMPANIES 164
11.6.2 RESPONSIVE COMPANIES 164
11.6.3 DYNAMIC COMPANIES 165
11.6.4 STARTING BLOCKS 165
FIGURE 45 CONTRAST MEDIA INJECTORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 165
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 166
TABLE 140 CONTRAST MEDIA INJECTORS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 166
TABLE 141 CONTRAST MEDIA INJECTORS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 167
11.7 COMPANY VALUATION & FINANCIAL METRICS 168
11.7.1 FINANCIAL METRICS 168
FIGURE 46 EV/EBITDA OF KEY VENDORS 168
11.7.2 COMPANY VALUATION 168
FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 168
11.8 BRAND/PRODUCT COMPARISON 169
FIGURE 48 CONTRAST MEDIA INJECTORS MARKET: BRAND/PRODUCT COMPARISON ANALYSIS 169
11.9 COMPETITIVE SCENARIO 169
11.9.1 PRODUCT LAUNCHES & APPROVALS 169
TABLE 142 CONTRAST MEDIA INJECTORS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024 169
11.9.2 DEALS 170
TABLE 143 CONTRAST MEDIA INJECTORS MARKET: DEALS, JANUARY 2021–MAY 2024 170
11.9.3 EXPANSIONS 170
TABLE 144 CONTRAST MEDIA INJECTORS MARKET: EXPANSIONS, JANUARY 2021–MAY 2024 170
12 COMPANY PROFILES 171
12.1 KEY PLAYERS 171
(Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and Competitive threats)*
12.1.1 BAYER AG 171
TABLE 145 BAYER AG: COMPANY OVERVIEW 171
FIGURE 49 BAYER AG: COMPANY SNAPSHOT (2023) 172
TABLE 146 BAYER AG: PRODUCTS OFFERED 172
TABLE 147 BAYER AG: DEALS, JANUARY 2021−MAY 2024 173
12.1.2 BRACCO IMAGING S.P.A. 175
TABLE 148 BRACCO IMAGING S.P.A.: COMPANY OVERVIEW 175
TABLE 149 BRACCO IMAGING S.P.A.: PRODUCTS OFFERED 175
TABLE 150 BRACCO IMAGING S.P.A.: DEALS, JANUARY 2021−MAY 2024 176
TABLE 151 BRACCO IMAGING S.P.A.: EXPANSIONS, JANUARY 2021−MAY 2024 176
12.1.3 GUERBET 177
TABLE 152 GUERBET: COMPANY OVERVIEW 177
FIGURE 50 GUERBET: COMPANY SNAPSHOT (2023) 178
TABLE 153 GUERBET: PRODUCTS OFFERED 178
TABLE 154 GUERBET: PRODUCT LAUNCHES, JANUARY 2021−MAY 2024 179
12.1.4 ULRICH GMBH & CO. KG 180
TABLE 155 ULRICH GMBH & CO. KG: COMPANY OVERVIEW 180
TABLE 156 ULRICH GMBH & CO. KG: PRODUCTS OFFERED 180
TABLE 157 ULRICH GMBH & CO. KG: DEALS, JANUARY 2021−MAY 2024 181
12.1.5 MEDTRON AG 182
TABLE 158 MEDTRON AG.: COMPANY OVERVIEW 182
TABLE 159 MEDTRON AG: PRODUCTS OFFERED 182
TABLE 160 MEDTRON AG: DEALS, JANUARY 2021−MAY 2024 183
12.1.6 NEMOTO KYORINDO CO., LTD. 184
TABLE 161 NEMOTO KYORINDO CO., LTD.: COMPANY OVERVIEW 184
TABLE 162 NEMOTO KYORINDO CO., LTD.: PRODUCTS OFFERED 184
12.1.7 SHENZHEN ANKE HIGH-TECH CO., LTD. 185
TABLE 163 SHENZHEN ANKE HIGH-TECH CO., LTD.: COMPANY OVERVIEW 185
TABLE 164 SHENZHEN ANKE HIGH-TECH CO., LTD.: PRODUCTS OFFERED 185
12.1.8 SINO MDT 186
TABLE 165 SINO MDT: COMPANY OVERVIEW 186
TABLE 166 SINO MDT: PRODUCTS OFFERED 186
12.1.9 APOLLO RT CO., LTD. 187
TABLE 167 APOLLO RT CO., LTD.: COMPANY OVERVIEW 187
TABLE 168 APOLLO RT CO., LTD.: PRODUCTS OFFERED 187
12.1.10 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD. 188
TABLE 169 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: COMPANY OVERVIEW 188
TABLE 170 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: PRODUCTS OFFERED 188
12.1.11 SHENZHEN ANTMED CO., LTD. 189
TABLE 171 SHENZHEN ANTMED CO., LTD.: COMPANY OVERVIEW 189
TABLE 172 SHENZHEN ANTMED CO., LTD.: PRODUCTS OFFERED 189
12.1.12 SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD. 190
TABLE 173 SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 190
TABLE 174 SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED 190
12.1.13 UNION MEDICAL SHENZHEN CO., LTD. 191
TABLE 175 UNION MEDICAL SHENZHEN CO., LTD.: COMPANY OVERVIEW 191
TABLE 176 UNION MEDICAL SHENZHEN CO., LTD.: PRODUCTS OFFERED 191
12.1.14 SPECTRUM MEDICAL TECHNOLOGIES 192
TABLE 177 SPECTRUM MEDICAL TECHNOLOGIES: COMPANY OVERVIEW 192
TABLE 178 SPECTRUM MEDICAL TECHNOLOGIES: PRODUCTS OFFERED 192
12.1.15 SHENZHEN BOON MEDICAL SUPPLY CO., LTD. 193
TABLE 179 SHENZHEN BOON MEDICAL SUPPLY CO., LTD.: COMPANY OVERVIEW 193
TABLE 180 SHENZHEN BOON MEDICAL SUPPLY CO., LTD.: PRODUCTS OFFERED 193
12.2 OTHER PLAYERS 194
12.2.1 SCW MEDICATH LTD.: COMPANY OVERVIEW 194
12.2.2 VYGON: COMPANY OVERVIEW 194
12.2.3 NANJING FOINOE CO., LTD.: COMPANY OVERVIEW 195
12.2.4 LEMER PAX: COMPANY OVERVIEW 195
12.2.5 COMECER S.P.A.: COMPANY OVERVIEW 196
12.2.6 TEMA SINERGIE S.P.A.: COMPANY OVERVIEW 196
12.2.7 SHEEN MAN CO., LTD.: COMPANY OVERVIEW 197
12.2.8 HONG KONG MEDI CO., LTD.: COMPANY OVERVIEW 197
12.2.9 QINGDAO HIPROVE MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW 198
12.2.10 SHANGHAI KINDLY ENTERPRISE DEVELOPMENT GROUP CO., LTD: COMPANY OVERVIEW 198
*Details on Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.
13 APPENDIX 199
13.1 DISCUSSION GUIDE 199
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 203
13.3 CUSTOMIZATION OPTIONS 205
13.4 RELATED REPORTS 205
13.5 AUTHOR DETAILS 206